Atika Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-39,700
| Closed | -$3.58M | – | 112 |
|
|
2021
Q3 | $3.58M | Sell |
39,700
-3,300
| -8% | -$298K | 0.21% | 86 |
|
|
2021
Q2 | $4.1M | Sell |
43,000
-23,000
| -35% | -$2.19M | 0.32% | 76 |
|
|
2021
Q1 | $7.52M | Sell |
66,000
-23,000
| -26% | -$2.62M | 0.65% | 58 |
|
|
2020
Q4 | $12.3M | Buy |
89,000
+10,400
| +13% | +$1.44M | 0.96% | 41 |
|
|
2020
Q3 | $6.46M | Sell |
78,600
-400
| -0.5% | -$32.9K | 0.53% | 55 |
|
|
2020
Q2 | $6.18M | Buy |
79,000
+40,500
| +105% | +$3.17M | 0.8% | 50 |
|
|
2020
Q1 | $1.71M | Buy |
38,500
+33,098
| +613% | +$1.47M | 0.33% | 62 |
|
|
2019
Q4 | $231K | Buy |
+5,402
| New | +$231K | 0.04% | 69 |
|
|
2019
Q3 | – | Sell |
-28,000
| Closed | -$1.78M | – | 76 |
|
|
2019
Q2 | $1.78M | Buy |
+28,000
| New | +$1.78M | 0.35% | 67 |
|
|
2015
Q3 | – | Sell |
-10,400
| Closed | -$1.07M | – | 69 |
|
|
2015
Q2 | $1.07M | Buy |
+10,400
| New | +$1.07M | 0.48% | 54 |
|